In a report released yesterday, Bruce Nudell from SunTrust Robinson reiterated a Buy rating on Merit Medical Systems (MMSI), with a price target of $75. The company’s shares opened today at $61.20.
According to TipRanks.com, Nudell is a 5-star analyst with an average return of 10.2% and a 68.6% success rate. Nudell covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Ra Medical Systems Inc, and Edwards Lifesciences.
Currently, the analyst consensus on Merit Medical Systems is a Strong Buy with an average price target of $73.83, a 20.6% upside from current levels. In a report issued on November 16, Needham also reiterated a Buy rating on the stock with a $73 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $66.34 and a one-year low of $41.25. Currently, Merit Medical Systems has an average volume of 412.4K.
Based on the recent corporate insider activity of 26 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups.
